M&G Plc Reduces Holdings in CME Group Inc. (NASDAQ:CME)

M&G Plc cut its holdings in CME Group Inc. (NASDAQ:CME) by 7.0% during the 3rd quarter, Holdings Channel reports. The fund owned 918,722 shares of the financial services provider’s stock after selling 68,946 shares during the period. CME Group comprises 1.0% of M&G Plc’s portfolio, making the stock its 18th biggest holding. M&G Plc’s holdings in CME Group were worth $203,038,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Radnor Capital Management LLC purchased a new position in CME Group during the third quarter valued at $209,000. Catalina Capital Group LLC bought a new position in shares of CME Group in the third quarter worth about $207,000. Capital Management Corp VA grew its stake in shares of CME Group by 4.5% during the 3rd quarter. Capital Management Corp VA now owns 34,568 shares of the financial services provider’s stock valued at $7,627,000 after acquiring an additional 1,496 shares during the period. FSM Wealth Advisors LLC purchased a new stake in CME Group in the 3rd quarter worth approximately $226,000. Finally, Catalyst Capital Advisors LLC raised its stake in CME Group by 77.8% during the 3rd quarter. Catalyst Capital Advisors LLC now owns 1,298 shares of the financial services provider’s stock worth $286,000 after acquiring an additional 568 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

CME stock opened at $221.17 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The business’s fifty day simple moving average is $221.36 and its two-hundred day simple moving average is $209.75. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The firm has a market cap of $79.64 billion, a price-to-earnings ratio of 23.26, a PEG ratio of 5.62 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business’s revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm posted $2.25 earnings per share. Analysts predict that CME Group Inc. will post 10.23 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on CME shares. Bank of America increased their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Piper Sandler upped their price objective on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. The Goldman Sachs Group lifted their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. JPMorgan Chase & Co. upped their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a research note on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $222.73.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,621 shares of company stock worth $3,441,063. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.